ArticlePoultry science2026
Bamboo polyphenols protects against Escherichia coli-induced liver injury in broilers by attenuating inflammatory responses.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian colibacillosis, caused by avian pathogenic Escherichia coli (APEC), is a highly prevalent disease worldwide and leads to substantial economic losses in the poultry industry annually. Despite the well-documented bioactivities of various plant polyphenols, the therapeutic potential of bamboo polyphenols (BP) against APEC infection remains largely unexplored. In this study, we investigated the antibacterial and anti-inflammatory effects of BP both in vitro and in vivo. The results demonstrated that BP inhibited the growth and killed APEC at relatively low concentrations in bacteriostatic and bactericidal assays. Liver histopathological examination and bacterial load determination revealed that treatment with BP reduced inflammatory cell infiltration and significantly decreased bacterial burden in liver tissue. Moreover, BP markedly downregulated the mRNA expression levels of inflammatory cytokines, chemokines, and pro-inflammatory markers, and suppressed the phosphorylation of p65, p38, and ERK1/2 both in vitro and in vivo. Additionally, BP inhibited LPS-induced ROS expression in vitro. These findings show that BP exerts antibacterial and anti-inflammatory effects by inhibiting bacterial growth, suppressing the NF-κB and MAPK pathways, and reducing ROS levels. This offers a new theoretical basis for controlling bacterial diseases in livestock and poultry, as well as a novel strategy against bacterial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.